CME Europe Limited will (subject to FCA approval) be a London-based FCA recognised investment exchange (RIE), positioning it in Europe's most important financial centre. It is a wholly owned subsidiary of CME Group with a dedicated Board of Directors and Management Team. As a UK registered company, it operates under English law and will be subject to formal recognition and supervision by the FCA and its successor bodies once approved
We have been guided by the strategic imperatives of transparency, efficiency and simplicity. Embedded is the desire to accommodate regional trading practises while providing transparent price discovery and risk management solutions. So CME Europe is making use of CME Globex, the world's leading electronic trading system linking 150 countries around the world, as its trading platform. Also CME ClearPort will be used to enter block & EFP trades, amongst others, to bring them under the rules of CME Europe and CME Clearing Europe for clearing. We have simplified our membership structure & criteria, including a low, one-off cost to join and supported by one straightforward set of membership documentation.
Clearing services are provided by CME Clearing Europe, an FCA recognised London-based clearing house (RCH) which is also a wholly owned subsidiary of CME Group.
We will offer a range of connectivity options, designed to be efficient as existing CME Globex and CME ClearPort connectivity will be utilised. Participants will have the choice of accessing directly through our global hubs, co-location, one of our clearing firms or via an ISV.
At launch, anticipated for Q2 2013, CME Europe will provide a unique product offering for international customers, starting with FX Futures and becoming multi-asset class in response to customer demand.
CME Europe benefits from the backing, track record and expertise of CME Group, the world's leading derivatives marketplace.
Robert Ray
Chief Executive Officer
Felix J. Carabello
Head of Strategic Sales
David Feltes
Chief Operating Officer
Paul Richardson
Chief Compliance Officer
To find out more about CME Europe
information@cmeeurope.com
+44 (0)20 3379 3700
Media enquiries
media@cmeeurope.com
+44 (0)20 3379 3830
Ray also served as Senior Vice President, Business Development, of CBOT from 2003. He joined CBOT in 2002 as Vice President, Equity Business Development, where he played a key role in creating a much more business-driven and customer-focused approach within the business development area. Prior to joining the CBOT, Ray served as a Principal at Robertson Stephens Inc. from February 2000 to October 2002, and was responsible for listed derivatives trading and served as Chicago Branch Manager. He also served as Senior Vice President, Institutional Equity Derivatives at Dean Witter Reynolds Inc. from July 1986 until July 1997, continuing with the successor company, Carr Futures, from July 1997 until February 2000 as Senior Vice President and Head of Listed Equity Derivatives.